THE ANGIOTENSIN-TYPE-2 RECEPTORS ARE INVOLVED IN AGE-RELATED CHANGES AND NEUROINFLAMMATION IN THE SUBSTANTIA NIGRA

THE ANGIOTENSIN-TYPE-2 RECEPTORS ARE INVOLVED IN AGE-RELATED CHANGES AND NEUROINFLAMMATION IN THE SUBSTANTIA NIGRA

Bibliographic Details
Main Authors:	Pablo Garrido-Gil, Ana Isabel Rodríguez Pérez, María A Pedrosa, María García-Garrote, Rita Valenzuela, Gemma Navarro-Brugal, Rafael Franco, José Luis Labandeira-García
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123008497

Similar Items

THE ANGIOTENSIN TYPE 2 RECEPTOR GENE MEDIATES SEXUAL DIMORPHISM IN MICROGLIAL INFLAMMATORY RESPONSES
by: Pablo Garrido-Gil, et al.
Published: (2023-10-01)

Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the <i>Substantia Nigra</i> of Male Rodents and Primary Mesencephalic Cultures
by: Aloia Quijano, et al.
Published: (2022-02-01)

Stereotaxic Injection of LPS into Mouse Substantia Nigra
by: Huiming Gao
Published: (2012-04-01)

ANGIOTENSIN TYPE-1 RECEPTOR AND ACE2 AUTOANTIBODIES IN PARKINSON´S DISEASE
by: Ana Isabel Rodríguez Pérez, et al.
Published: (2023-10-01)

Substance P infusion into substantia nigra of the rat: behavioural analysis and involvement of striatal dopamine.
by: Kelley, A, et al.
Published: (1979)

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
by: Jay S Schneider
Published: (2018-01-01)

Effect of stress on neuroinflammation in the substantia nigra and striatum of LRRK2 (R1441G) mouse model for Parkinson’s disease
by: Chen, Jiayi
Published: (2015)

Substantia nigra alterations in mice modeling Parkinson’s disease
by: I. N. Rozhkova, et al.
Published: (2024-11-01)

Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
by: Carmen M. Labandeira, et al.
Published: (2022-06-01)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
by: Paola Feraco, et al.
Published: (2021-06-01)

Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
by: Jose L. Labandeira-Garcia, et al.
Published: (2022-02-01)

Diagnostic value of combined assessment of olfaction and substantia nigra hyperechogenicity for Parkinson's disease
by: N. López Hernández, et al.
Published: (2015-10-01)

Intranigral Administration of β-Sitosterol-β-D-Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra
by: Claudia Luna-Herrera, et al.
Published: (2020-01-01)

Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra.
by: Garcia-Reitboeck, P, et al.
Published: (2013)

Behavioral effects of aminochrome and dopachrome injected in the rat substantia nigra.
by: Díaz-Véliz, G, et al.
Published: (2002)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
by: T. N. Seyfried, et al.
Published: (2018-06-01)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
by: Sayyed Shahid Hussain, et al.
Published: (2023-08-01)

Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease
by: Lei Liu, et al.
Published: (2023-09-01)

Anatomical and functional organization of the human substantia nigra and its connections
by: Yu Zhang, et al.
Published: (2017-08-01)

The effect of titanium dioxide nanoparticles on mice midbrain substantia nigra
by: Zahra Heidari, et al.
Published: (2019-07-01)

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
by: Conant Stephanie B, et al.
Published: (2006-10-01)

The Degenerating Substantia Nigra as a Susceptible Region for Gene Transfer-Mediated Inflammation
by: Valeria Roca, et al.
Published: (2011-01-01)

DOPAMINE INCREASE ADULT NEUROGENESIS IN THE VENTRICULAR-SUBVENTRICULAR ZONE VIA DOPAMINE D3 RECEPTORS AND RECIPROCAL INTERACTIONS WITH ANGIOTENSIN TYPE 2 RECEPTOR.
by: Juan Parga, et al.
Published: (2023-10-01)

Behavioural response to bilateral injections of substance P into the substantia nigra of the rat.
by: Kelley, A, et al.
Published: (1978)

ISOLATION AND CHARACTERIZATION OF SINGLE NEURONS FROM GUINEA-PIG SUBSTANTIA-NIGRA
by: Hainsworth, A, et al.
Published: (1990)

Eyes as Gateways for Environmental Light to the Substantia Nigra: Relevance in Parkinson’s Disease
by: Stefania Romeo, et al.
Published: (2014-01-01)

Stereotaxic Infusion of LPS into Rat Substantia Nigra via Osmotic Minipump
by: Huiming Gao
Published: (2012-04-01)

Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson’s disease
by: Dhairya A. Lakhani, et al.
Published: (2024-01-01)

Local iron deficiency in the substantia nigra directly contributes to hyperlocomotion phenotypes
by: Zhuo Wang, et al.
Published: (2022-06-01)

Extracellular Vesicles and Their Renin–Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson’s Disease
by: Maria A. Pedrosa, et al.
Published: (2023-11-01)

Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primates
by: Tiziano Balzano, et al.
Published: (2024-06-01)

Characterization of clock proteins in the substantia nigra and subthalamic nucleus of the Sapajus apella primate
by: Leila Maria Guissoni Campos, et al.
Published: (2024-11-01)

Brain renin-angiotensin system and dopaminergic cell vulnerability
by: Jose L Labandeira-Garcia, et al.
Published: (2014-07-01)

COMPARISON OF LOCUS COERULEUS PATHOLOGY WITH SUBSTANTIA NIGRA PATHOLOGY IN A PROGRESSIVE MONKEY MODEL OF PARKINSON'S DISEASE
by: Megan Carrillo Díaz De Argandoña, et al.
Published: (2023-10-01)

Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse
by: Maria Regoni, et al.
Published: (2021-05-01)

The behavioural effects of EOS-induced changes in substantia nigra GABA levels [proceedings].
by: Koob, G, et al.
Published: (1976)

Investigation of non-cholinergic acetylcholinesterase, and related peptides in an in vitro preparation of the substantia nigra
by: Whyte, K, et al.
Published: (2001)

Connectivity-based segmentation of the substantia Nigra in human and its implications in Parkinson's disease.
by: Menke, R, et al.
Published: (2010)

Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease.
by: Menke, R, et al.
Published: (2010)

The effect of cannabinoid type Ⅱ receptor on the excitability of substantia nigra dopaminergic neurons
by: Sha Zhao, et al.
Published: (2025-02-01)